Evotec SE (EVO) Net Cash Flow (2009 - 2026)
Evotec SE (EVO) posted Net Cash Flow of -$41491.2 for Q1 2026, down 100.03% sequentially from $145.4 million in Q4 2025, and down 119.31% YoY from $214896.0 in Q1 2025.
Evotec SE (EVO) Net Cash Flow (2009 - 2026) Analysis & Trends
Evotec SE has reported Net Cash Flow for 9 years, with the latest figure at -$41491.2 in Q1 2026.
- Quarterly Net Cash Flow fell 119.31% year-over-year to -$41491.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.2 million (up 163.41% YoY) and the FY2025 annual result came in at $145.3 million, up 163.4% from the prior year.
- Net Cash Flow eased to -$41491.2 in Q1 2026 per EVO's latest filing, from $145.4 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $145.4 million in Q4 2025 and troughed at -$270.2 million in Q4 2022.
- A 5-year average of -$14.8 million and a median of -$18919.2 in 2025 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow tumbled 1082.02% in 2024, then jumped 163.54% in 2025.
- Over 5 years, Net Cash Flow stood at -$270.2 million in 2022, then jumped by 137.83% to $102.2 million in 2023, then sank by 323.77% to -$228.8 million in 2024, then soared by 163.54% to $145.4 million in 2025, then tumbled by 100.03% to -$41491.2 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$41491.2, $145.4 million, and -$101628.3 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.76 Bn | 40.11 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.39 Bn | 30.71 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.45 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.64 Bn | 15.25 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Evotec SE | 691.84 Mn | 691.37 Mn | - | -41,491.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,491.23 |
| Mar 31, 2026 | -41,491.23 |
| Dec 31, 2025 | 145.39 Mn |
| Dec 31, 2025 | 145.39 Mn |
| Sep 30, 2025 | -101,628.30 |
| Sep 30, 2025 | -101,628.30 |
| Jun 30, 2025 | -11,413.55 |
| Jun 30, 2025 | -11,413.55 |
| Mar 31, 2025 | -18,919.19 |
| Mar 31, 2025 | -18,919.19 |
| Dec 31, 2024 | -228.80 Mn |
| Dec 31, 2024 | -228.80 Mn |
| Sep 30, 2024 | 10,428.69 |
| Sep 30, 2024 | 10,428.69 |
| Jun 30, 2024 | -216,177.64 |
| Jun 30, 2024 | -216,177.64 |
| Mar 31, 2024 | -92,291.86 |
| Mar 31, 2024 | -92,291.86 |
| Dec 31, 2023 | 102.25 Mn |
| Dec 31, 2023 | 102.25 Mn |